Innovation & R&D Strategy
With a global view of pipeline momentum, competitive intensity and strategic fit, support portfolio planning, BD opportunity screening, target screening and indication competition assessment.
Learn more
Global Innovative Drug Intelligence with
Deep China Market Insights
Integrating global innovative drug intelligence, China market insights and essential analytics to help strategy, BD, R&D, clinical and medical teams make more informed decisions.
Three Value Pillars
Learn More
Track The Global Innovation Landscape
Track priority assets, competitors and development progress to stay ahead of global innovation trends.
Read China Market Signals
Develop a deeper view of China market dynamics and competitive landscape to identify opportunities and risks.
Support Critical Decisions
Turn intelligence, insights and analytics into clearer decision inputs for cross-functional teams.
Analysis and Insights for Critical
Pharma Decisions
Support the analysis and insights behind the decisions that shape innovation strategy, clinical execution and commercial success across the pharma lifecycle.
Clinical Development Strategy
Guide clinical planning by tracking trial landscapes, milestone shifts and evolving development paths across global and China markets.
Learn more
Commercial & Access Strategy
Focus on China regulatory filing strategy, market access strategy and launch path planning to support access timing decisions and commercialization execution.
Learn more
Built for Cross - Functional Pharma Teams
Learn MoreStrategy
Landscape, asset direction and market opportunity
BD
Target screening, pipeline scanning and deal context
R&D
Target, indication and development path
Clinical
Trial footprint, investigators and progress signals
Medical
Evidence, treatment dynamics and scientific cues
Regulatory
Submission pathways, regulatory timing and market-specific requirements
Market Analysis
Market sizing, competitive dynamics and commercialization opportunity assessment
Market Access
Access pathways, reimbursement signals and pricing environment
Also used by investment teams and CRO / CDMO partners evaluating assets, partner fit and outsourcing landscape shifts
Investment
Asset screening, deal flow, financing signals and portfolio diligence
CRO / CDMO
Partner selection, service capability benchmarking and outsourcing landscape tracking
Pharma Reach at Scale
3000+
Enterprises Served
800K+
Registered Users
92%
MNC Coverage
75%
China Top 100 Pharma Coverage
Explore Core Modules
Learn MoreWho We Serve
Our platform is trusted by over 3,000 organisations across the global pharmaceutical and life sciences landscape, including leading consulting firms, CROs, and investment institutions.
DXY Insight Database
Empowering enterprises to make more precise decisions and operate with greater efficiency.